Viking Therapeutics (NASDAQ:VKTX) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.06, Briefing.com reports. During the same quarter last year, the firm posted ($0.19) earnings per share. Viking Therapeutics Stock Up 28.3 % […]
More Stories
Raymond James Financial Inc. Buys Shares of 87,080 Helmerich & Payne, Inc. (NYSE:HP)
Raymond James Financial Inc. purchased a new position in Helmerich & Payne, Inc. (NYSE:HP – Free Report) in the fourth...
Mariner LLC Trims Stock Position in GFL Environmental Inc. (NYSE:GFL)
Mariner LLC reduced its stake in shares of GFL Environmental Inc. (NYSE:GFL – Free Report) by 50.3% during the fourth...
Raymond James Financial Inc. Makes New Investment in Roku, Inc. (NASDAQ:ROKU)
Raymond James Financial Inc. purchased a new stake in shares of Roku, Inc. (NASDAQ:ROKU – Free Report) during the 4th...
Raymond James Financial Inc. Buys Shares of 511,352 Sandstorm Gold Ltd. (NYSE:SAND)
Raymond James Financial Inc. purchased a new position in shares of Sandstorm Gold Ltd. (NYSE:SAND – Free Report) in the...
Raymond James Financial Inc. Acquires Shares of 377,370 89bio, Inc. (NASDAQ:ETNB)
Raymond James Financial Inc. bought a new position in 89bio, Inc. (NASDAQ:ETNB – Free Report) during the 4th quarter, according...
Raymond James Financial Inc. Makes New $3.10 Million Investment in Bancolombia S.A. (NYSE:CIB)
Raymond James Financial Inc. bought a new stake in Bancolombia S.A. (NYSE:CIB – Free Report) during the 4th quarter, according...